Despite a rebound in 2023, financial markets continue to face inflationary pressures, elevated interest rates, mixed macroeconomic signals, and geopolitical concerns. In light of these challenges, T. Rowe Price contends that healthcare investing would provide investors with essential defensive characteristics and the opportunity to achieve target investment growth thresholds.
“Health care has historically displayed relative resilience during periods of market uncertainty. This is due to the general inelasticity of demand for many health care products and services,” writes Taymour Tamaddon, Portfolio Manager a T. Rowe Price.
As per Tamaddon, healthcare investing also offers attractive growth potential through advancements in drug therapies and medical devices. The innovative nature of products and regulatory barriers, according to him, create opportunities for companies in this sector to command strong pricing power.
Additionally, the asset manager says that structural socioeconomic trends support ongoing growth in healthcare spending, driven by an ageing population, advancements in technology, and medical discovery.
“The coronavirus pandemic served as a wake‑up call for global governments…This is positive for the sector and supportive of a potentially exciting period of innovation, consolidation, and optimization in this pivotal area of society,” opines Tamaddon.
Subsequently, he elucidates the three subsectors within the healthcare sector that appear particularly attractive. They are managed care, medical devices, and therapeutics.
Furthermore, Tamaddon identifies the U.S. presidential election in 2024 as a major near-term uncertainty for the healthcare sector. This is because election years often witness policy variations depending on the presidential winner and candidates’ stances.
On the outlook for the healthcare sector, the asset manager said: “The macroeconomic environment looks set to be challenging through 2023 and beyond. Indeed, we believe a recession is likely. Health care tends to be less cyclically sensitive, and its defensive characteristics should help the sector weather any slowdown in the broader economy.”
Read the complete insight here.
Read more
City of London Investment Management
The case for Closed-End Funds in Emerging Markets
Closed-end funds have long been a niche investment vehicle, but what makes them particularly compelling in today’s emerging markets environment?
J.P. Morgan
The “golden era for gold”
Gold rallies on peaking yields, firm demand, and a weaker dollar outlook.
Apollo Multi Asset Management
Why absolute return matters more than ever
A disciplined absolute return strategy can deliver stability and low correlation in volatile markets.
HSBC Asset Management
Europe & EMs poised to eclipse U.S. equity dominance
Small caps in Europe and EM outperform, reversing years of large-cap dominance.
